IFN-β treatment modulates the CD28/CTLA-4-mediated pathway for IL-2 production in patients with relapsing -remitting multiple sclerosis
- 1 December 2004
- journal article
- research article
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 10 (6) , 630-635
Abstract
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system probably mediated by Th1 lymphocytes. IFN-b is an established therapy for relapsing MS patients, although the mechanisms underlying its efficacy are yet to be well characterized. We determined IL-2 production, CD25 expression and T-cell proliferation from relapsing -remitting MS patients before and three months after starting therapy. A decrease in the percentage of CD80-induced IL-2-producing cells was observed after in vivo IFN-b treatment. These data support that one of the immunomodulatory effects of IFN-b treatment in MS may be a limitation of the autoimmune response modifying the CD80:CD28/CTLA-4 pathway.Keywords
This publication has 27 references indexed in Scilit:
- IFN- β 1a Modulates the Expression of CTLA-4 and CD28 Splice Variants in Human Mononuclear Cells: Induction of Soluble IsoformsJournal of Interferon & Cytokine Research, 2001
- New insight into immunological mechanisms of venom immunotherapyCurrent Opinion in Allergy and Clinical Immunology, 2001
- Therapeutic strategies in multiple sclerosis. I. ImmunotherapyPhilosophical Transactions of the Royal Society B: Biological Sciences, 1999
- Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-β1b-treated multiple sclerosis patientsMultiple Sclerosis Journal, 1998
- Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy.Journal of Clinical Investigation, 1997
- Multiple Sclerosis: A Coordinated Immunological Attack against Myelin in the Central Nervous SystemCell, 1996
- CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xLImmunity, 1995
- New perspectives of C1328-137-mediated T cell costimulationImmunity, 1995
- Interferon β decreases T cell activation and interferon γ production in multiple sclerosisJournal of Neuroimmunology, 1993
- Rating neurologic impairment in multiple sclerosisNeurology, 1983